Comparative genomic profiling of glandular bladder tumours
-
Published:2020-03-20
Issue:3
Volume:477
Page:445-454
-
ISSN:0945-6317
-
Container-title:Virchows Archiv
-
language:en
-
Short-container-title:Virchows Arch
Author:
Maurer Angela, , Ortiz-Bruechle Nadina, Guricova Karolina, Rose Michael, Morsch Ronja, Garczyk Stefan, Stöhr Robert, Bertz Simone, Golz Reinhard, Reis Henning, Bremmer Felix, Zimpfer Annette, Siegert Sabine, Kristiansen Glen, Schwamborn Kristina, Gassler Nikolaus, Knuechel Ruth, Gaisa Nadine T.ORCID
Abstract
AbstractPrimary glandular bladder tumours (bladder adenocarcinoma [BAC], urachal adenocarcinoma [UAC], urothelial carcinoma with glandular differentiation [UCg]) are rare malignancies with histological resemblance to colorectal adenocarcinoma (CORAD) in the majority of this subgroup. Definite case numbers are very low, molecular data are limited and the pathogenesis remains poorly understood. Therefore, this study was designed to complement current knowledge by in depth analysis of BAC (n = 12), UAC (n = 13), UCg (n = 11) and non-invasive glandular lesions (n = 19). In BAC, in addition to known alterations in TP53, Wnt, MAP kinase and MTOR pathway, mutations in SMAD4, ARID1A and BRAF were identified. Compared to published data on muscle invasive bladder cancer (BLCA) and CORAD, UCg exhibited frequent “urothelial” like alterations while BAC and UAC were characterised by a more “colorectal” like mutational pattern. Immunohistochemically, there was no evidence of DNA mismatch repair deficiency or PD-L1 tumour cell positivity in any sample. Depending on the used antibody 0–45% of BAC, 0–30% of UCg and 0% UAC cases exhibited PD-L1 expressing tumour associated immune cells. A single BAC (9%, 1/11) showed evidence of ARID1A protein loss, and two cases of UCg (20%, 2/10) showed loss of SMARCA1 and PBRM1, respectively. Taken together, our data suggest at least in part involvement of similar pathways driving tumourigenesis of adenocarcinomas like BAC, UAC and CORAD independent of their tissue origin. Alterations of TERT and FBXW7 in single cases of intestinal metaplasia further point towards a possible precancerous character in line with previous reports.
Funder
Medizinische Fakultät, RWTH Aachen University
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine
Reference50 articles.
1. Arslan B, Bozkurt IH, Yonguc T, Vadar E, Degirmenci T, Kozacioglu Z, Gunlosoy B, Minareci S (2015) Clinical features and outcomes of nontransitional cell carcinomas of the urinary bladder: analysis of 125 cases. Urol Ann 7:177–182. https://doi.org/10.4103/0974-7796.150533 2. Kaatsch P, Spix C, Katalinic A, Hentschel S, Lutmmann S, Stegmaier C, Caspritz S, Christ M, Ernst A, Fokerts J, Hansmann J, Klein S, Kranzhöfer K, Kunz B, Manegold K, Penzkofer A, Treml K, Weg-Remers S, Wittenberg K, Baras N, Barnes B, Bertz J, Buttmann-Schweiger, DS, Fiebig J, Franke M, Haberland J, Kraywinkel K, Wienecke A, Wolf U (2015) Harnblase. In: Robert Koch-Institut und die Gesellschaft der epidemioloigschen Krebsregister in Deutschland e.V. 3. (ed) Krebs in Deutschland 2011/2012, 10th edn. Robert Koch-Insitut, Berlin, pp 106-109 4. Soave A, Schmidt S, Dahlem R, Minner S, Engel O, Kluth LA, John LM, Hansen J, Schmid M, Sauter G, Shariat SF, Fisch M, Rink M (2015) Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy? Urol Oncol 33:21.e1–21.e9. https://doi.org/10.1016/j.urolonc.2014.10.013 5. Lee YJ, Moon KC, Jeong CW, Kwak C, Kim HH, Ku JH (2014) Impact of squamous and glandular differentiation on oncologic outcomes in upper and lower tract urothelial carcinoma. PLoS One 9:e107027. https://doi.org/10.1371/journal.pone.0107027
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|